Skip to main content
    C

    Coherus BioSciences Inc (CHRS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.48
    -0.03 (-5.42%)

    Market Cap: $81.21M

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Coherus BioSciences Inc (CHRS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Coherus BioSciences (CHRS) has a latest price of $0.48 on Nov 17, 2026. Its price fell 59.8% over the past 12 months. The month-end price fell 97.0% over the 10 years through Oct 2026, a compound annual decline of 29.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $28.15 in Dec 2016 and its lowest $0.73 in Jun 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CHRS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CHRS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 64.0%, and over 6 months it fell 67.7%. The month-end price fell 75.2% over the 3 years through Oct 2026, a compound annual decline of 37.2%.

    PeriodChange
    1 month-50.1%
    3 months-64.0%
    6 months-67.7%
    12 months-59.8%
    12 months, with dividends-59.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-75.2%-37.2%
    5 years-95.0%-45.2%
    10 years-97.0%-29.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 99.0%, and its weakest was 2017, when it fell 68.7%.

    YearCloseChange
    2026 through Oct 2026$0.83-41.5%
    2025$1.42+2.9%
    2024$1.38-58.6%
    2023$3.33-58.0%
    2022$7.92-50.4%
    2021$15.96-8.2%
    2020$17.38-3.5%
    2019$18.00+99.0%
    2018$9.05+2.8%
    2017$8.80-68.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 53.2% below its 50-day average of $1.02 and 67.0% below its 200-day average of $1.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.48
    50-day average$1.02-53.2%
    200-day average$1.45-67.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 85.6%.

    MeasureValue
    1-year beta2.05
    Largest fall, 1 year-80.9%
    Largest fall, 3 years-85.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CHRS

    What is CHRS's 1-year price change?

    Coherus BioSciences's price fell 59.8% over the past 12 months. With dividends included, the 12-month total return was -59.8%.

    What is CHRS's 5-year price change?

    Coherus BioSciences's month-end price fell 95.0% over the 5 years through Oct 2026, a compound annual decline of 45.2%. These figures leave out dividends.

    What is CHRS's beta?

    Coherus BioSciences's 1-year beta against the S&P 500 is 2.05, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.9%.

    Is the CHRS chart free?

    Yes. Advanced Charting for CHRS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.